{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:02:21Z","timestamp":1779235341935,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/s11882-004-0037-x","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T15:05:43Z","timestamp":1181660743000},"page":"17-24","source":"Crossref","is-referenced-by-count":34,"title":["Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs"],"prefix":"10.1007","volume":"4","author":[{"given":"Ronald A.","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"37_CR1","volume-title":"Allergy: Principles and Practice, edn 6.","author":"D Stevenson","year":"2003","unstructured":"Stevenson D, Simon RA, Zuraw B: Sensitivity to aspirin and non-steroidal anti-inflammatory drugs. In Allergy: Principles and Practice, edn 6. Edited by Middleton E Jr, Ellis EF, Yunginer JW, et al. St. Louis: Mosby; 2003. This reference is a current and comprehensive review of the topic of respiratory but also other reactions (especially cutaneous reactions to aspirin and other NSAIDs) that inhibit cyclooxygenase."},{"key":"37_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","volume":"87","author":"D Stevenson","year":"2001","unstructured":"Stevenson D, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy 2001, 87:177\u2013180.","journal-title":"Ann Allergy"},{"key":"37_CR3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","volume":"68","author":"M Samter","year":"1968","unstructured":"Samter M, Beers R Jr.: Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968, 68:975\u2013983.","journal-title":"Ann Intern Med"},{"key":"37_CR4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.7326\/0003-4819-71-3-479","volume":"71","author":"B Giraldo","year":"1969","unstructured":"Giraldo B, Blumenthal MN, Spink WW: Aspirin intolerance and asthma: a clinical and immunological study. Ann Intern Med 1969, 71:479\u2013496.","journal-title":"Ann Intern Med"},{"key":"37_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/0091-6749(72)90014-0","volume":"50","author":"JR McDonald","year":"1972","unstructured":"McDonald JR, Mathison DA, Stevenson DD: Aspirin intolerance in asthma, detection by oral challenge. J Allergy Clin Immunol 1972, 50:198\u2013207.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","volume":"89","author":"MP Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002, 89:474\u2013478. Presents the up-to-date Scripps Clinic experience in the clinical presentation of AERD and its natural history. Should help clinicians identify these individuals.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"37_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","volume":"16","author":"A Szczeklik","year":"2000","unstructured":"Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma: AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000, 16:432\u2013436.","journal-title":"Eur Respir J"},{"key":"37_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0889-8561(05)70038-2","volume":"18","author":"D Stevenson","year":"1998","unstructured":"Stevenson D: Adverse reactions to nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 1998, 18:773\u2013798.","journal-title":"Immunol Allergy Clin North Am"},{"key":"37_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/0091-6749(83)90439-6","volume":"71","author":"WW Pleskow","year":"1983","unstructured":"Pleskow WW, Stevenson DD, Mathison DA, et al.: Aspirinsensitive rhinosinusitis\/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983, 71:574\u2013579.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/25.1.5","volume":"25","author":"JCP Weber","year":"1986","unstructured":"Weber JCP, Eissigman WK: Pulmonary alveolitis and NSAIDs: fact or fiction. Br J Rheumatol 1986, 25:5\u20136.","journal-title":"Br J Rheumatol"},{"key":"37_CR11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1378\/chest.83.2.280","volume":"83","author":"DA Nader","year":"1983","unstructured":"Nader DA, Schillaci RF: Pulmonary infiltrates with eosinophilia due to naproxene. Chest 1983, 83:280\u2013282.","journal-title":"Chest"},{"key":"37_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.251.1.65","volume":"1","author":"AJ Buscaglia","year":"1984","unstructured":"Buscaglia AJ, Cowden FE: Pulmonary infiltrates associated with naproxene. JAMA 1984, 1:65\u201366.","journal-title":"JAMA"},{"key":"37_CR13","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1001\/archinte.152.7.1521","volume":"152","author":"SD Goodwin","year":"1992","unstructured":"Goodwin SD, Glenny RW: Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia: review of the literature and Food and Drug Administration Adverse Drug Reaction reports. Arch Intern Med 1992, 152:1521\u20131524.","journal-title":"Arch Intern Med"},{"key":"37_CR14","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1001\/jama.252.14.1853b","volume":"252","author":"AV Londino","year":"1984","unstructured":"Londino AV, Wolf GL, Calabro JJ: Naproxen and pneumonitis. JAMA 1984, 252:1853\u20131854.","journal-title":"JAMA"},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1081-1206(10)62432-5","volume":"85","author":"JD Pauls","year":"2000","unstructured":"Pauls JD, Simon RA, Daffern PJ, et al.: Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol 2000, 85:40\u201345.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"37_CR16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1081-1206(10)62575-6","volume":"85","author":"D Stevenson","year":"2000","unstructured":"Stevenson D, Simon RA, Mathison DA, et al.: Montelukast is only partially effective in inhibiting aspirin responses in aspirin sensitive asthmatics. Ann Allergy Asthma Immunol 2000, 85:477\u2013482.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"37_CR17","first-page":"159","volume":"63","author":"E Nizankowska","year":"1989","unstructured":"Nizankowska E, Szczeklik A: Glucocorticosteroids attenuate aspirin-precipitated adverse reactions in aspirin-intolerant patients with asthma. Ann Allergy 1989, 63:159\u2013162.","journal-title":"Ann Allergy"},{"key":"37_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/thx.34.5.654","volume":"34","author":"A Szczeklik","year":"1979","unstructured":"Szczeklik A, Serwonska M: Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine. Thorax 1979, 34:654\u2013657.","journal-title":"Thorax"},{"key":"37_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1398-9995.1981.tb01831.x","volume":"36","author":"R Dahl","year":"1981","unstructured":"Dahl R: Oral and inhaled sodium cromoglycate in challenges with food and acetylsalicylic acid. Allergy 1981, 36:161\u2013172.","journal-title":"Allergy"},{"key":"37_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2500\/108854188778995020","volume":"9","author":"DD Stevenson","year":"1988","unstructured":"Stevenson DD: Oral challenges to detect aspirin and sulfite sensitivity in asthma. N Engl Reg Allergy Proc 1988, 9:135\u2013142.","journal-title":"N Engl Reg Allergy Proc"},{"key":"37_CR21","first-page":"129","volume":"5","author":"SR Bianco","year":"1977","unstructured":"Bianco SR, Robuschi M, Petrigni G: Aspirin-induced tolerance in aspirin-asthma detected by a new challenge test. IRCS J Med Sci 1977, 5:129\u2013136.","journal-title":"IRCS J Med Sci"},{"key":"37_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0091-6749(89)90330-8","volume":"84","author":"GD Phillips","year":"1989","unstructured":"Phillips GD, Foord R, Holgate ST: Inhaled lysine-aspirin as a broncho-provocation procedure with aspirin in aspirinsensitive asthma. J Allergy Clin Immunol 1989, 84:232\u2013241.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.93.03050527","volume":"3","author":"B Dahlen","year":"1990","unstructured":"Dahlen B, Zetterstrom O: Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 1990, 3:527\u2013534.","journal-title":"Eur Respir J"},{"key":"37_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0091-6749(98)70163-0","volume":"101","author":"M Milewski","year":"1998","unstructured":"Milewski M, Mastalerz L, Nizankowska E, et al.: Nasal provocation test with lysine-aspirin for diagnosis of aspirinsensitive asthma. J Allergy Clin Immunol 1998, 101:581\u2013586.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR25","first-page":"189","volume":"30","author":"MF Widal","year":"1922","unstructured":"Widal MF, Abrami P, Lermeyez J: Anaphylaxie et idiosyncrasie. Presse Med 1922, 30:189\u2013192.","journal-title":"Presse Med"},{"key":"37_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","volume":"66","author":"DD Stevenson","year":"1980","unstructured":"Stevenson DD, Simon RA, Mathison DA: Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980, 66:82\u201385.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0091-6749(82)90081-1","volume":"69","author":"WW Pleskow","year":"1982","unstructured":"Pleskow WW, Stevenson DD, Mathison DA, et al.: Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982, 69:11\u201319.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","volume":"98","author":"DD Stevenson","year":"1996","unstructured":"Stevenson DD, Hankammer MA, Mathison DA: Long-term ASA desensitization-treatment of aspirin-sensitive asthmatic patients: Clinical outcome studies. J Allergy Clin Immunol 1996, 98:751\u2013758.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","volume":"60","author":"A Szczeklik","year":"1977","unstructured":"Szczeklik A, Gryglewski RJ, Czernigwska-Mysik G: Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977, 60:276\u2013284.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2222.1976.tb01896.x","volume":"6","author":"JC Delaney","year":"1976","unstructured":"Delaney JC: The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976, 6:177\u2013184.","journal-title":"Clin Allergy"},{"key":"37_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","volume":"84","author":"RA Settipane","year":"1989","unstructured":"Settipane RA, Stevenson DD: Cross-sensitivity with cetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1989, 84:26\u201333.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR32","first-page":"462","volume-title":"Progress in Allergy and Clinical Immunology.","author":"DD Stevenson","year":"1989","unstructured":"Stevenson DD: Cross-reactivity between aspirin and other drugs\/dietary chemicals: a critical review. In Progress in Allergy and Clinical Immunology. Edited by Pichler WJ, Stadler MM, Dahinden CA, et al. Lewiston, NY: Hogrefe and Huber; 1989:462\u2013473."},{"key":"37_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0091-6749(95)70299-7","volume":"96","author":"BA Feigenbaum","year":"1995","unstructured":"Feigenbaum BA, Stevenson DD, Simon RA: Lack of crosssensitivity to IV hydrocortisone in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1995, 96:545\u2013548.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1067\/mai.2001.116290","volume":"108","author":"DD Stevenson","year":"2001","unstructured":"Stevenson DD, Simon R: Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001, 108:47\u201351. First comprehensive report describing the safety of COX-2 inhibitors in a large number of patients with AERD who underwent blinded, placebo-controlled challenges with rofecoxib.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR35","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/art.10426","volume":"46","author":"KM Woessner","year":"2002","unstructured":"Woessner KM, Simon RA, Stevenson DD: The safety of celecoxib in patients with aspirin sensitive asthma. Arthritis Rheum 2002, 46:2201\u20132206.","journal-title":"Arthritis Rheum"},{"key":"37_CR36","first-page":"232","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971, 231:232\u2013235.","journal-title":"Nature"},{"key":"37_CR37","first-page":"513","volume":"64","author":"DA Moneret-Vautrin","year":"1990","unstructured":"Moneret-Vautrin DA, Hsieh V, Wayoff M, et al.: Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990, 64:513\u2013518.","journal-title":"Ann Allergy"},{"key":"37_CR38","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","volume":"149","author":"K Sladek","year":"1994","unstructured":"Sladek K, Dworski R, Soja J, et al.: Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Care Med 1994, 149:940\u2013946.","journal-title":"Am J Respir Care Med"},{"key":"37_CR39","first-page":"15","volume":"8","author":"T Yamashita","year":"1989","unstructured":"Yamashita T, Tsuyi H, Maeda N, et al.: Etiology of nasal polyps associated with aspirin-sensitive asthmatic subjects. Rhinology 1989, 8:15\u201324.","journal-title":"Rhinology"},{"key":"37_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1398-9995.1980.tb01782.x","volume":"35","author":"B Samuelsson","year":"1980","unstructured":"Samuelsson B, Hammarstroem S, Murphy RC, et al.: Leukotrienes and slow reacting substance of anaphylaxis. Allergy 1980, 35:375\u2013381.","journal-title":"Allergy"},{"key":"37_CR41","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","volume":"143","author":"PE Christie","year":"1991","unstructured":"Christie PE, Tagari P, Ford-Hutchinson AW, et al.: Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991, 143:1025\u20131029.","journal-title":"Am Rev Respir Dis"},{"key":"37_CR42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.93.05060693","volume":"5","author":"DM Smith","year":"1992","unstructured":"Smith DM, Hawksworth RJ, Thien FC, et al.: Urinary leukotriene E4 in bronchial asthma. Eur Respir J 1992, 5:693\u2013699.","journal-title":"Eur Respir J"},{"key":"37_CR43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/09031936.93.03050588","volume":"3","author":"A Szczeklik","year":"1990","unstructured":"Szczeklik A: The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990, 3:588\u2013593.","journal-title":"Eur Respir J"},{"key":"37_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0091-6749(99)70106-5","volume":"104","author":"A Szczeklik","year":"1999","unstructured":"Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999, 104:5\u201313.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/0091-6749(92)90137-Q","volume":"90","author":"UR Juergens","year":"1992","unstructured":"Juergens UR, Christiansen SC, Stevenson DD, et al.: Arachidonic acid metabolism in monocytes of aspirinsensitive patients before and after oral aspirin challenge. J Allergy Clin Immunol 1992, 90:636\u2013645.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1164\/ajrccm.161.2.9902034","volume":"161","author":"ML Kowalski","year":"2000","unstructured":"Kowalski ML, Pawliczak R, Wozniak J, et al.: Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000, 161:391\u2013398.","journal-title":"Am J Respir Crit Care Med"},{"key":"37_CR47","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1067\/mai.2003.1491","volume":"111","author":"M Pierzchalska","year":"2003","unstructured":"Pierzchalska M, Szabo Z, Sanak M, et al.: Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. J Allergy Clin Immunol 2003, 111:1041\u20131048.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR48","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJMoa013508","volume":"347","author":"AR Sousa","year":"2002","unstructured":"Sousa AR, Parikh A, Scadding G, et al.: Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirinsensitive rhinosinusitis. N Engl J Med 2002, 347:1493\u20131499.","journal-title":"N Engl J Med"},{"key":"37_CR49","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","volume":"143","author":"PE Christie","year":"1991","unstructured":"Christie PE, Tagari P, Ford-Hutchinson AW, et al.: Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991, 143:1025\u20131029.","journal-title":"Am Rev Respir Dis"},{"key":"37_CR50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","volume":"149","author":"K Sladek","year":"1994","unstructured":"Sladek K, Dworski R, Soja J, et al.: Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Resp Crit Care Med 1994, 149:940\u2013946.","journal-title":"Am J Resp Crit Care Med"},{"key":"37_CR51","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1067\/mai.2003.1387","volume":"111","author":"G Bochenek","year":"2003","unstructured":"Bochenek G, Nagraba K, Nizankowska E, et al.: A controlled study of 9a, 11b-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls alter aspirin challenge. J Allergy Clin Immunol 2003, 111:743\u2013749.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","volume":"153","author":"P Sestini","year":"1996","unstructured":"Sestini P, Armetti L, Gambaro G, et al.: Inhaled PEG2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996, 153:572\u2013575.","journal-title":"Am J Respir Crit Care Med"},{"key":"37_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0091-6749(95)70002-1","volume":"96","author":"UR Juergens","year":"1995","unstructured":"Juergens UR, Christiansen SC, Stevenson DD, et al.: Inhibition of monocyte leukotriene B4 production following aspirin desensitization. J Allergy Clin Immunol 1995, 96:148\u2013156.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","volume":"157","author":"B Dahlen","year":"1998","unstructured":"Dahlen B, Nizankowska E, Szczeklik A: Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998, 157:1187\u20131194.","journal-title":"Am J Respir Crit Care Med"},{"key":"37_CR55","doi-asserted-by":"crossref","first-page":"A975","DOI":"10.1164\/ajrccm.155.6.9196107","volume":"155","author":"P Kuna","year":"1997","unstructured":"Kuna P, Malmstrom K, Dahlen SE, et al.: Montelukast (MK-0476) a cysLT1 receptor antagonist improves asthma control in aspirin-intolerant asthmatic patients. Am J Respir Care Med 1997, 155:A975.","journal-title":"Am J Respir Care Med"},{"key":"37_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","volume":"86","author":"JA Sweet","year":"1990","unstructured":"Sweet JA, Stevenson DD, Simon RA, et al.: Long-term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J Allergy Clin Immunol 1990, 86:59\u201365.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR57","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","volume":"98","author":"DD Stevenson","year":"1996","unstructured":"Stevenson DD, Hankammer MA, Mathison DA, et al.: Longterm ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J Allergy Clin Immunol 1996, 98:751\u2013758.","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1067\/mai.2003.7","volume":"111","author":"MP Berges-Gimeno","year":"2003","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD: Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003, 111:180\u2013186. This report presents a tremendous amount of data on the effectiveness of aspirin desensitization treatment. Presents data, for the first time, on percent responders and also percent drop outs (and why).","journal-title":"J Allergy Clin Immunol"},{"key":"37_CR59","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1081-1206(10)61803-0","volume":"90","author":"MP Berges-Gimeno","year":"2003","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD: Early effects of aspirin: desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003, 90:338\u2013341. First look at how soon one can expect to see benefit from aspirin desensitization treatment with aspirin in AERD.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"37_CR60","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","volume":"32","author":"MP Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD: The effect of leukotriene modifier drugs on aspirin-induced asthma and rhinitis. Clin Exp Allergy 2002, 32:1491\u20131496.","journal-title":"Clin Exp Allergy"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0037-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-004-0037-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0037-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-004-0037-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:58:55Z","timestamp":1683889135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-004-0037-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s11882-004-0037-x","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}